Bioblast Pharma Ltd. (ORPN) Gained 12.83% or 0.24 To Price $2.11 On Monday


Bioblast Pharma Ltd. (ORPN) gained 12.83% or 0.24 to $2.11. It is near 34247 shares traded, which is 75.78% compare to the average total volume 45193. The market cap of ORPN is $7.05 million. The year to date change is -15.77%. The 52 week price range is from $1.49 to $5.99. Price of ORPN have changed -5.56% during last week. It have changed -35.74% over last month, -24.29% over last 3 months, -10.95% over last 6 months and -33.21% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.64. It is 25.12% above current price. The 200-day Moving Averages for ORPN is 2.60. It is 23.22% above current price. The 52-week High is 5.99. It is 183.89% from the current price. The 52-week Low is 1.49. It is -29.38% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 2.97 on 2018-03-15. Short % to float is 3.94%. There are some statistics of ORPN. It is has market cap $7.05 million. The share outstanding is 3.34 million. The average volume is 45193. The percent of top 15 Institution holding is 6.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -111.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -95.72%.


Tags:

Share this post